Drug intelligence / Profile preview

rabies vaccine (Vero cell) (ee2755)

Development stage
Unknown
Lead developer
Shandong Yidu Biotechnology
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Yi Du Kang Da is a freeze-dried rabies vaccine (Vero cell) for human use developed and manufactured by Shandong Yidu Biotechnology. It is an inactivated viral vaccine produced by propagating the rabies virus in Vero cell cultures, followed by purification and lyophilization. The vaccine is indicated for post-exposure prophylaxis (PEP) to prevent rabies infection following animal bites or other exposures. It is typically administered via intramuscular injection using either the 5-dose Essen schedule (1-1-1-1-1) or the 4-dose 2-1-1 (Zagreb) schedule. As a post-marketing Phase IV study (CTR20252241) evaluates its adherence across these schedules, the vaccine is established in the Chinese market for rabies prevention.

Brand names
Yi Du Kang Da
Other names
Freeze-dried Rabies Vaccine (Vero Cell) for Human Use亦度康达
02

Targets

Rabies virus nucleoprotein (N protein)RABV-G (Rabies virus glycoprotein)

Beyond the preview

Go deeper on rabies vaccine (Vero cell) (ee2755).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies vaccine (Vero cell) (ee2755).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call